Royal Peptides products are offered exclusively for laboratory research, analytical, and scientific applications. Not for human or veterinary use.
01Research Product Information
Royal Peptides supplies compounds intended for controlled laboratory research and analytical applications.
- For research and analytical use only
- Not intended for human consumption or administration
- Not intended for veterinary use
- Not represented as a drug, medicine, or therapeutic product
- Laboratory researchers are responsible for appropriate protocols and controls
02Lyophilized Product Format
Where applicable, Royal Peptides research materials are supplied in lyophilized form.
Lyophilization is a freeze-drying process used to remove moisture from material under controlled conditions.
- Material appearance may differ between compounds and production lots
- Lyophilized material may appear as a cake, film, or fragmented material
- The quantity of visible material may appear small relative to vial size
- Visual appearance alone does not establish identity or purity
03Storage & Laboratory Handling
Storage requirements may vary by compound, formulation, and production lot. Refer to the product label and available product-specific documentation.
- Protect research materials from excessive heat
- Limit unnecessary exposure to direct light and moisture
- Keep containers securely closed when stored
- Follow product-specific temperature requirements when provided
- Use appropriate laboratory contamination-control procedures
04Packaging & Quality Documentation
Packaging components may vary slightly between production lots. This can include vial closures, cap styles, label positioning, and external packaging.
- Check the product label and lot identifier before laboratory use
- Inspect the vial and closure for visible shipping damage
- Packaging design may differ between batches
- Lot-specific analytical documentation may be available in our COA library
Retatrutide 10-Vial Bulk Kit RT
Retatrutide 10 Vial Bulk Kit – Retatrutide Research Reference
Order Retatrutide 10 Vial Bulk Kit directly from Royal Peptides: Same-Lot Kits, Lower Cost per Vial, lot-tested before release. Running a longer study? The Retatrutide bulk kit keeps all ten vials on the same manufacturing lot, so results stay comparable from the first vial to the last. If you only need one or two, a single reta vial is the better fit; for larger programs see peptides wholesale usa pricing.
Retatrutide, also identified as LY3437943 or LY-3437943, is an investigational peptide compound associated in the scientific literature with activity at the GIPR, GLP-1R, and GCGR receptor systems. Royal Peptides supplies Retatrutide in multi-vial formats exclusively as laboratory research material.
This research reference brings together compound identity, receptor classification, 10-vial kit information, analytical documentation, batch traceability, and related Royal Peptides research resources in one location.
Research Use Only
Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.
Order Online
Buy Retatrutide 10 Vial Bulk Kit Online
Pick your strength with the selector at the top of this page and add Retatrutide 10 Vial Bulk Kit to your cart. Prices are per vial or per kit as shown, and every order ships with lot documentation.
Need larger quantities of Retatrutide? Kits and wholesale boxes lower the unit price; see our peptides wholesale usa options.
01
Compound Identity
Retatrutide / LY3437943
Retatrutide is the official name associated with the investigational peptide also referenced by the development identifiers LY3437943 and LY-3437943 in public scientific records.
These identifiers establish the identity of the published reference substance. They should be distinguished from lot-specific analytical data used to characterize an individual production batch of physical research material.
Reference data: molecular information above reflects the current public GSRS Retatrutide substance record. It is reference information for the published entity and does not replace analytical characterization of a specific Royal Peptides production lot.
02
Research Targets
GIPR, GLP-1R & GCGR Research Profile
Public pharmacology records classify Retatrutide as a triple receptor agonist associated with three receptor systems: the glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor.
Glucose-Dependent Insulinotropic Polypeptide Receptor
GIPR is one of the three receptor systems associated with the published pharmacological profile of Retatrutide.
Glucagon-Like Peptide-1 Receptor
GLP-1R is another component of the multi-receptor profile described for the Retatrutide reference compound in scientific pharmacology records.
Glucagon Receptor
GCGR represents the third receptor system included in the published triple-receptor classification of Retatrutide.
Receptor information summarizes the published scientific classification of the Retatrutide reference compound. It is provided for research context and is not a therapeutic, dosing, administration, or clinical-use statement.
03
Scientific Context
An Investigational Research Compound
Retatrutide has been investigated in an extensive clinical development program under the LY3437943 development identifier. Public trial records continue to identify Retatrutide as an investigational compound.
Published research and clinical-trial records can establish scientific context for the reference molecule, but they do not independently establish the identity, purity, composition, or characteristics of a separate physical research sample.
Compound Identification
Retatrutide, LY3437943, CAS 2381089-83-2, and UNII NOP2Y096GV provide established identifiers for locating corresponding public scientific records.
Receptor Classification
Public pharmacology resources associate the Retatrutide reference compound with GIPR, GLP-1R, and GCGR.
Published Research
Peer-reviewed literature and registered studies provide historical and experimental context concerning the investigational Retatrutide molecule.
Lot-Specific Documentation
Characterization of supplied research material should rely on documentation corresponding to the applicable physical production lot.
04
Research Kit Format
Retatrutide 10-Vial Research Kits
This product page is dedicated to Retatrutide 10-vial research kits. Available research quantities are organized through the product variation selector above so laboratories can select among currently available kit configurations without requiring a separate indexed product page for every variation.
Each kit variation contains ten vials associated with the selected nominal research quantity. Current pricing, variation availability, and inventory status are displayed by the live WooCommerce product record above.
10-Vial Configuration
Multi-vial research kits consolidate ten vials within a single product configuration while retaining the applicable product and batch identification.
Multiple Research Quantities
Available kit quantities are managed as variations of this primary Retatrutide kit product rather than separate near-duplicate product pages.
Batch Identification
Product and lot identification should be retained with associated analytical and laboratory research records.
Bulk Research Requirements
Laboratories requiring quantities beyond standard 10-vial research kits can review Royal Peptides wholesale and bulk research procurement information.
05
Analytical Verification
Retatrutide Batch Documentation & COAs
Royal Peptides maintains analytical documentation for applicable Retatrutide production lots. Analytical reports should be evaluated in relation to the specific batch or lot represented by the tested sample rather than treated as universal documentation for every Retatrutide material.
The Royal Peptides Certificate of Analysis library provides a central location for reviewing available analytical records and matching applicable documentation to research material.
Identify
Confirm the Retatrutide product, selected research quantity, and available batch or lot identification.
Match
Locate analytical documentation associated with the corresponding production lot whenever lot-level information is available.
Review
Review the laboratory, sample identifiers, analytical methods, reported measurements, and other information contained in the report.
Preserve
Retain relevant product, lot, analytical, receipt, and storage records within the laboratory’s research documentation.
06
Research Traceability
Compound Record vs. Production Lot
Scientific databases describe the referenced Retatrutide substance. Published literature describes material and experimental conditions evaluated by individual investigators. Analytical documentation, by contrast, can provide information about the specific sample evaluated from an individual production lot.
Royal Peptides therefore distinguishes reference-compound information from lot-specific analytical documentation. Maintaining that distinction supports clearer research records and material traceability.
07
Research Procurement
10-Vial Kits & Bulk Research Quantities
Laboratories evaluating larger research quantities can compare Retatrutide 10-vial kits with wholesale and bulk research procurement. Royal Peptides maintains separate resources for standard kit formats and larger-volume research requirements.
The Royal Peptides wholesale research guide covers multi-vial procurement, unit and price-per-milligram comparison, analytical documentation, lot traceability, fulfillment, and considerations relevant to larger research orders.
08
Related Research
Explore Retatrutide Research Resources
Royal Peptides maintains separate resources for different research-material formats, analytical documentation, and comparative research topics. These pages are kept distinct to provide more specific information without duplicating the complete 10-vial kit record.
Retatrutide Single Vials → Individual Retatrutide research-material quantities outside the 10-vial kit format. Retatrutide COA Records → Review available Royal Peptides analytical documentation and applicable lot records. Retatrutide vs. Tirzepatide → Review a research-focused comparison of two distinct investigational peptide compounds. Wholesale Research Kits → Information for laboratories evaluating larger multi-vial and bulk research-material quantities.
09
Retatrutide FAQ
Retatrutide Research Questions
What is Retatrutide?
Retatrutide is the official name associated with the investigational peptide compound also identified as LY3437943 or LY-3437943. Public pharmacology records describe it as a triple receptor agonist associated with GIPR, GLP-1R, and GCGR.
Is LY3437943 the same identifier associated with Retatrutide?
Yes. LY3437943 and LY-3437943 are development identifiers associated with Retatrutide in public scientific and regulatory records.
What receptor systems are associated with Retatrutide research?
Public pharmacology records describe the Retatrutide reference compound as an agonist associated with the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR).
What is the CAS number associated with Retatrutide?
The validated GSRS substance record lists CAS Registry Number 2381089-83-2 for Retatrutide. This is a reference-compound identifier and does not replace lot-specific analytical documentation for supplied research material.
What does a Retatrutide 10-vial kit contain?
This product is organized as a 10-vial research kit. Selecting a variation above determines the nominal research quantity associated with each vial in that kit. Current variations and inventory are displayed by the live product selector.
Are Retatrutide single vials available separately?
Yes. Royal Peptides maintains a separate Retatrutide single-vial product for laboratories requiring individual research quantities rather than a 10-vial kit.
Is analytical documentation available for Retatrutide?
Royal Peptides maintains analytical documentation for applicable research-material lots. Researchers should use the available lot or batch information associated with the material to locate corresponding records in the Royal Peptides COA library.
Why should a Retatrutide COA be matched to its lot?
An analytical report describes the sample evaluated by the testing laboratory. Matching documentation to the applicable production lot supports traceability between the physical research material and its analytical record.
Is Retatrutide an approved medicine?
Retatrutide remains an investigational compound. Royal Peptides supplies its Retatrutide material exclusively for laboratory, analytical, and scientific research and not for human or veterinary use.
Does Royal Peptides provide Retatrutide dosing or administration instructions?
No. Royal Peptides does not provide dosing, prescribing, injection, administration, treatment, or personal-use instructions for this research material.
10
Scientific References
Public Retatrutide Records
Researchers can independently review authoritative public records used for Retatrutide compound identification, receptor classification, and clinical-development context.
NCATS / GSRS — Retatrutide Validated substance record containing the Retatrutide name, LY3437943 development identifiers, CAS number, FDA UNII, peptide classification, sequence, and reference molecular information. NIH PubChem — Retatrutide / LY3437943 Public Retatrutide substance record identifying LY3437943 and the published GIPR, GLP-1R, and GCGR receptor profile. ClinicalTrials.gov — Retatrutide Studies U.S. National Library of Medicine registry records for clinical research involving Retatrutide / LY3437943. Eli Lilly Research & Development Pipeline Developer research and pipeline information concerning investigational compounds and clinical development.
Quality Documentation
Retatrutide 10 Vial Bulk Kit Lot Testing & COA
Every Retatrutide 10 Vial Bulk Kit lot is independently tested before release; results are listed with our third party tested peptides. For background reading, see published Retatrutide research on PubMed.
Related Research
Researchers Also Order
Compounds often studied alongside Retatrutide:
Buying Questions
Buying Retatrutide 10 Vial Bulk Kit
Where can I buy Retatrutide 10 Vial Bulk Kit?
Order Retatrutide 10 Vial Bulk Kit directly from Royal Peptides. Choose a format in the Buy section, check out securely and your order ships from U.S. stock with lot documentation.
How fast do orders ship?
Orders are dispatched from U.S. inventory, usually within one business day, with tracking.
Laboratory Research Material
Royal Peptides Retatrutide is supplied exclusively for laboratory, analytical, and scientific research purposes. It is not intended for human or veterinary use, ingestion, injection, administration, pharmaceutical compounding, diagnostic use, therapeutic use, clinical use, or personal experimentation. View Analytical Documentation → Retatrutide Single Vials →
Specifications
Product information pulled directly from WooCommerce.
COA / Testing
Independent third-party lab reports for this compound. Each report applies to the batch shown.
Shipping & Storage
Shipping options and delivery estimates are shown at checkout. Refer to the product label for storage requirements.
